Risk of Cancer in Patients with Eating Disorders: A Population-based Study

10.4103/TPSY.TPSY_16_19

Yi-Chun Liu；Mong-Liang Lu；Ko-Jung Chen；Yao-Hsu Yang；Vincent Chin-Hung Chen

anorexia nervosa ； bulimia nervosa ； cancer ； carcinogenicity

台灣精神醫學

33卷2期（2019 / 06 / 01）

76 - 82

英文

Objectives: Patients with eating disorder (ED) have been associated with some risk factors for cancer, including nutritional deficiency, chaotic life styles, alcohol or tobacco use, dysfunctional immune system, and impaired organ functions. In this study, we intended to study the risk of cancer in ED patients. Methods: During the period of January 1998 to December 2013, 13,755 ED patients were identified from Taiwan's National Health Insurance Research Database. We enrolled 13,276 patients as study cohort, and 53,104 patients that had never been diagnosed with ED as age-.and sex-matched comparisons. Participants were monitored for diagnoses of cancer during the follow-up period. We used the Cox proportional hazards model to investigate the risk of cancer between patients with ED and those without ED. Results: Compared with the non-ED controls, the study cohort had significantly higher prevalence of comorbidities, alcohol abuse, tobacco use disorder, and chronic obstructive pulmonary disease. After adjusting demographic data and comorbidities, there was no significant risk for later occurrence of cancer in ED patients, irrespective of anorexia nervosa (AN) type (hazard ratio [HR] = 1.10, 95% confidence interval [CI], = 0.83 - 1.47, nonsignificant difference) or non-AN type (HR = 0.98, 95% CI = 0.79 - 1.23, nonsignificant difference). Conclusion: There is no established evidence to support the relationship between cancer incidence and ED.

1. Booij, L,Casey, KF,Antunes, JM(2015).DNA methylation in individuals with anorexia nervosa and in matched normal-eater controls: a genome-wide study.Int J Eat Disord,48,874-882.
2. Brewster, DH,Nowell, SL,Clark, DN(2015).Risk of oesophageal cancer among patients previously hospitalised with eating disorder.Cancer Epidemiol,39,313-320.
3. Chieh-Yu, L,Yunh-Tai, H,Yi-Li, C(2006).Incorporating development stratification of Taiwan townships into sampling design of large scale health interview survey.J Health Manage,4,1-22.
4. Cossrow, N,Pawaskar, M,Witt, EA(2016).Estimating the prevalence of binge eating disorder in a community sample from the United States: comparing DSM-IV-TR and DSM-5 criteria.J Clin Psychiatry,77,e968-974.
5. Dong, J,Thrift, AP(2017).Alcohol, smoking and risk of oesophago-gastric cancer.Best Pract Res Clin Gastroenterol,31,509-517.
6. Gaudiani, JL,Mehler, PS(2016).Rare medical manifestations of severe restricting and purging: “zebras,” missed diagnoses, and best practices.Int J Eat Disord,49,331-344.
7. Gravina, G,Milano, W,Nebbiai, G(2018).Medical complications in anorexia and bulimia nervosa.Endocr Metab Immune Disord Drug Targets,18,477-488.
8. Karamanis, G,Skalkidou, A,Tsakonas, G(2014).Cancer incidence and mortality patterns in women with anorexia nervosa.Int J Cancer,134,1751-1757.
9. Kimiz-Gebologlu, I,Gulce-Iz, S,Biray-Avci, C(2018).Monoclonal antibodies in cancer immunotherapy.Mol Biol Rep,45,2935-2940.
10. Machado, PP,Gonçalves, S,Hoek, HW(2013).DSM-5 reduces the proportion of EDNOS cases: evidence from community samples.Int J Eat Disord,46,60-65.
11. Mellemkjaer, L,Emborg, C,Gridley, G(2001).Anorexia nervosa and cancer risk.Cancer Causes Control,12,173-177.
12. Mellemkjaer, L,Papadopoulos, FC,Pukkala, E(2015).Cancer incidence among patients with anorexia nervosa from Sweden, Denmark and Finland.PLoS One,10,e0128018.
13. Michels, KB,Ekbom, A(2004).Caloric restriction and incidence of breast cancer.JAMA,291,1226-1230.
14. Mullai, N,Sivarajan, KM,Shiomoto, G(1991).Barrett esophagus.Ann Intern Med,114,913.
15. Pandey, N,Chauhan, A,Jain, N(2018).TLR4 polymorphisms and expression in solid cancers.Mol Diagn Ther,22,683-702.
16. Papadopoulos, FC,Pantziaras, I,Lagiou, P(2009).Age at onset of anorexia nervosa and breast cancer risk.Eur J Cancer Prev,18,207-211.
17. Pennathur, A,Gibson, MK,Jobe, BA(2013).Oesophageal carcinoma.Lancet,381,400-412.
18. Root, TL,Pisetsky, EM,Thornton, L(2010).Patterns of co-morbidity of eating disorders and substance use in Swedish females.Psychol Med,40,105-115.
19. Smink, FR,van Hoeken, D,Hoek, HW(2012).Epidemiology of eating disorders: incidence, prevalence and mortality rates.Curr Psychiatry Rep,14,406-414.
20. Smink, FR,van Hoeken, D,Oldehinkel, AJ(2014).Prevalence and severity of DSM-5 eating disorders in a community cohort of adolescents.Int J Eat Disord,47,610-619.
21. Stice, E,Marti, CN,Rohde, P(2013).Prevalence, incidence, impairment, and course of the proposed DSM-5 eating disorder diagnoses in an 8-year prospective community study of young women.J Abnorm Psychol,122,445-457.
22. Umar, A,Dunn, BK,Greenwald, P(2012).Future directions in cancer prevention.Nat Rev Cancer,12,835-48.
23. van der Veen, EL,Bensch, F,Glaudemans, AW(2018).Molecular imaging to enlighten cancer immunotherapies and underlying involved processes.Cancer Treat Rev,70,232-44.
24. Vaz-Leal, FJ,Rodriguez-Santos, L,Melero-Ruiz, MJ(2010).Psychopathology and lymphocyte subsets in patients with bulimia nervosa.Nutr Neurosci,13,109-115.
25. Westmoreland, P,Krantz, MJ,Mehler, PS(2016).Medical complications of anorexia nervosa and bulimia.Am J Med,129,30-37.